Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1

Yingzi Cui1,2, Ruchao Peng1, Hao Song1,3

  • 1Chinese Academy of Sciences (CAS) Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101 Beijing, China.

Insights

KREMEN1 (KRM1) is a receptor for Coxsackievirus A10 (CV-A10), causing hand-foot-and-mouth disease. This study reveals KRM1

Area of Science:

  • Structural biology
  • Virology
  • Molecular mechanisms of viral entry

Background:

  • Coxsackievirus A10 (CV-A10) causes hand-foot-and-mouth disease (HFMD), a significant global infant health concern.
  • The precise mechanisms of CV-A10 viral entry into host cells remain incompletely understood.
  • KREMEN1 (KRM1) has been identified as a functional receptor for CV-A10.

Purpose of the Study:

  • To elucidate the atomic structures of CV-A10 viral particles and their complex with KRM1.
  • To understand the molecular interactions governing CV-A10 binding to KRM1.
  • To investigate the role of KRM1 in CV-A10 entry and uncoating under different pH conditions.

Main Methods:

  • Determination of atomic structures of CV-A10 viral particles and KRM1 complexes using X-ray crystallography or cryo-electron microscopy.
  • Biochemical assays to confirm receptor binding and virion uncoating.
  • Analysis of key residues involved in KRM1-CV-A10 interactions.

Main Results:

  • Atomic structures reveal KRM1 binds to the CV-A10 VP1 subunit above the canyon, spanning adjacent asymmetric units.
  • Key KRM1-binding residues are conserved across KRM1-dependent enteroviruses, suggesting a common entry mechanism.
  • KRM1 binding triggers pocket factor release, an event accelerated by acidic pH, facilitating CV-A10 virion uncoating in vitro.

Conclusions:

  • KREMEN1 acts as a crucial receptor for CV-A10 entry, mediating viral particle binding and subsequent uncoating.
  • The findings provide high-resolution structural insights into the CV-A10 entry pathway.
  • KRM1 functions as a dual-action receptor, facilitating both initial attachment and the initiation of viral uncoating.

Related Concept Videos

Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.2K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
109.7K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K